Billal Tedbirt
Clermont-ferrand, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France': reply from authors.
Journal: The British journal of dermatology
Published: June 12, 2026
Daratumumab as a therapeutic option for rituximab-recalcitrant pemphigus.
Journal: The Journal of investigative dermatology
Published: May 18, 2026
Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies.
Journal: The New England journal of medicine
Published: May 06, 2026
Efficacy and Safety of Rituximab in Pemphigus Foliaceus: A Systematic Review and Meta-analysis.
Journal: Dermatology and therapy
Published: March 22, 2026
Tocilizumab for severe and refractory mucous membrane pemphigoid.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 04, 2025
Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus.
Journal: The British journal of dermatology
Published: November 06, 2025
Persistence of anti-Desmoglein 3 Antibodies in Patients with Pemphigus Vulgaris in Clinical Remission is Associated with Restricted Isotype Diversity and Desmoglein 3 Ectodomain Recognition.
Journal: The British journal of dermatology
Published: October 23, 2025
Incidence and mortality of mucous membrane pemphigoid in France.
Journal: The British journal of dermatology
Published: September 28, 2025
European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.
European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 21, 2025
Risk of persistent hypogammaglobulinaemia in children with autoimmune bullous dermatoses treated with rituximab.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 12, 2025
Ustekinumab as a potential therapeutic agent in bullous pemphigoid: a biologic and clinical proof-of-concept study.
Journal: The British journal of dermatology
Published: April 18, 2025
Amoxicillin-induced linear IgA bullous dermatosis mimicking erythema multiforme: a case report.
Journal: Skin health and disease
Published: March 24, 2025
Last Updated: 09/26/2026